Objetivo
RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with proven expertise and a strong track record in RSV research. The academic partners are leaders in RSV epidemiology, clinical RSV research, health economics, and vaccinology; and key opinion leaders with advisory roles in European and national public health bodies, health technology agencies and vaccine advisory groups. EFPIA participants (AZ, GSK, JPNV, Novavax, Pfizer, and SP) have active clinical research programmes to develop lead candidates for treatment and prevention of RSV in infants, adults and the elderly. As part of RESCEU, EFPIA participants will contribute expertise in a wide range of fields including infectious disease, clinical medicine, immunology, epidemiology, biostatistics, biomarker development, global health, and health economics. RESCEU’s aim is to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics. RESCEU aims to provide sustainable longer term impact on RSV disease burden and thus make a significant contribution to improved health and wellbeing in Europe.
The project will comprise 6 work packages. WP 1-3 will identify and marshal data from large-scale systematic reviews of epidemiological and cost studies, disease registries, linked routine (national) healthcare and claims datasets and will establish a framework for and assemble data from RSV surveillance in Europe to estimate RSV disease burden on health services and inform economic models.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
H2020-JTI-IMI2-2015-06-two-stage
Consulte otros proyectos de esta convocatoriaRégimen de financiación
RIA - Research and Innovation actionCoordinador
EH8 9YL Edinburgh
Reino Unido
Ver en el mapa
Participantes (18)
2000 Antwerpen
Ver en el mapa
3584 CX Utrecht
Ver en el mapa
OX1 2JD Oxford
Ver en el mapa
La participación finalizó
28006 Madrid
Ver en el mapa
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.
SW7 2AZ LONDON
Ver en el mapa
15703 Santiago De Compostela
Ver en el mapa
20520 Turku
Ver en el mapa
3721 MA Bilthoven
Ver en el mapa
2300 Kobenhavn S
Ver en el mapa
9713 GZ Groningen
Ver en el mapa
35127 Padova
Ver en el mapa
151 85 Sodertaelje
Ver en el mapa
CT13 9NJ Sandwich
Ver en el mapa
1330 Rixensart
Ver en el mapa
69007 Lyon
Ver en el mapa
2340 Beerse
Ver en el mapa
20878 Gaithersburg
Ver en el mapa
08007 Barcelona
Ver en el mapa
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.